Shenzhen Salubris Pharmaceuticals Co.,Ltd.’s Net Profit Rose 56.1% in First Quarter of 2022

Shenzhen Salubris Pharmaceuticals Co.,Ltd. (深圳信立泰药业股份有限公司) (002294.SZ) reported a net profit of 236.8 million yuan in the first quarter of 2022, up 56.1% year-on-year.

Meanwhile, the company posted 935.2 million yuan in revenue, up 22.1% year-on-year.

At the end of the reporting period, it had 9.7 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 16.9%.